348 related articles for article (PubMed ID: 32407339)
41. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Forte T; Niu J; Lockwood GA; Bryant HE
Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
[TBL] [Abstract][Full Text] [Related]
42. Characterization of high risk human papilloma virus genotypes associated with oropharyngeal cancers in a Nigerian population.
Akhiwu BI; Akhiwu HO; Afolaranmi T; Chuwang N; Elugbe A; Shedrach A; Luka P; Odumosu P; Olorunfemi PO; Adoga SA; Silas O; Ugwu BT; Ladeinde A; Imade GE; Sagay AS
Pan Afr Med J; 2021; 38():40. PubMed ID: 33777308
[TBL] [Abstract][Full Text] [Related]
43. Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland, Australia.
Emmett S; Jenkins G; Boros S; Whiteman DC; Panizza B; Antonsson A
ANZ J Surg; 2017 Sep; 87(9):714-719. PubMed ID: 27091484
[TBL] [Abstract][Full Text] [Related]
44. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
45. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Maxwell JH; Grandis JR; Ferris RL
Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
[TBL] [Abstract][Full Text] [Related]
46. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
47. Oropharyngeal cancer incidence trends: diminishing racial disparities.
Brown LM; Check DP; Devesa SS
Cancer Causes Control; 2011 May; 22(5):753-63. PubMed ID: 21380619
[TBL] [Abstract][Full Text] [Related]
48. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
[TBL] [Abstract][Full Text] [Related]
49. Trends in human papillomavirus-related oropharyngeal cancer in Israel.
Amit M; Ilana K; Avraham SP; Binenbaum Y; Bachar G; Billan S; Zaarura S; Czerninski R; Bar-Tov M; Maly A; Akrish S; Gil Z
Head Neck; 2016 Apr; 38 Suppl 1():E274-8. PubMed ID: 25545260
[TBL] [Abstract][Full Text] [Related]
50. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
51. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
Smith EM; Ritchie JM; Summersgill KF; Klussmann JP; Lee JH; Wang D; Haugen TH; Turek LP
Int J Cancer; 2004 Feb; 108(5):766-72. PubMed ID: 14696105
[TBL] [Abstract][Full Text] [Related]
52. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma.
Zhang Y; Sturgis EM; Dahlstrom KR; Wen J; Liu H; Wei Q; Li G; Liu Z
Cancer Res; 2013 Oct; 73(19):5996-6003. PubMed ID: 23928994
[TBL] [Abstract][Full Text] [Related]
53. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.
Blomberg M; Nielsen A; Munk C; Kjaer SK
Int J Cancer; 2011 Aug; 129(3):733-41. PubMed ID: 20878955
[TBL] [Abstract][Full Text] [Related]
54. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
55. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Zhang Y; Fakhry C; D'Souza G
JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
[TBL] [Abstract][Full Text] [Related]
56. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
57. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
Parkin DM; Louie KS; Clifford G
Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma.
Feller L; Wood NH; Khammissa RA; Lemmer J
Head Face Med; 2010 Jul; 6():15. PubMed ID: 20633288
[TBL] [Abstract][Full Text] [Related]
59. Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite.
Silfverschiöld M; Sjövall J; Wennerberg J; Östensson E; Greiff L
PLoS One; 2019; 14(7):e0220534. PubMed ID: 31356646
[TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.
St Guily JL; Jacquard AC; Prétet JL; Haesebaert J; Beby-Defaux A; Clavel C; Agius G; Birembaut P; Okaïs C; Léocmach Y; Soubeyrand B; Pradat P; Riethmuller D; Mougin C; Denis F
J Clin Virol; 2011 Jun; 51(2):100-4. PubMed ID: 21527208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
